Unveiling the Cause of Premature Birth
A scientific study has revealed that certain antibodies may trigger premature birth by targeting the protein "IL-1RA," which inhibits the inflammatory molecule "IL-1 beta" responsible for stimulating uterine contractions. These antibodies appeared early in pregnancy and were found at higher levels in women who delivered before 37 weeks compared to those who delivered at the expected time. Experiments conducted on mice injected with these antibodies showed increased inflammation and damage to the placenta, demonstrating a potential mechanism that could explain some cases of premature birth. The drug "Kineret," used to treat inflammatory conditions, might serve as a potential preventive option; however, further studies are needed to confirm its safety and effectiveness during pregnancy. While these findings are significant, researchers emphasize that other factors continue to play a role in preterm labor and hope that this study will aid in developing methods for early detection of at-risk women and in providing future preventive options.
Notice: This Is an AI-Generated Summary
Comments (0)